Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stopping trouble before it starts.

Jon Clardy1

  • 1Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 240 Longwood Avenue, Boston, Massachusetts 02115, USA. jon_clardy@hms.harvard.edu

ACS Chemical Biology
|December 14, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aerocavin Is an Antibiotic with Potent and Specific Anti-Neisserial Activity.

ACS infectious diseases·2026
Same author

Dietary sulfur amino acids enhance anti-tumor immunity in colon cancer via an NKT cell-XCL1-cDC1 circuit.

Immunity·2026
Same author

From an Interest in Molecules to a Fascination with Microbes.

Annual review of microbiology·2026
Same author

<i>Blautia wexlerae</i> Transforms Dietary Fatty Acids to Activate Enteroendocrine Signaling and Improve Metabolic Health in Mice and Humans.

bioRxiv : the preprint server for biology·2026
Same author

Ecological interactions drive metabolomic diversification in Amazonian <i>Pseudonocardia</i> symbionts.

mSystems·2026
Same author

Aerocavin is an antibiotic with potent and specific anti-Neisserial activity.

bioRxiv : the preprint server for biology·2026
Same journal

Inositol Thiophosphates as Inhibitors of Mammalian, Plant, and Fungal Phytases.

ACS chemical biology·2026
Same journal

Synthesis and Characterization of the Spectroscopic and Imaging Utilities of Two Indole-Based Cyan Fluorescent Nucleoside Analogues.

ACS chemical biology·2026
Same journal

Indole Ring Expansion and Rearrangement-Enabled Quinoline Scaffold Formation in the Biosynthesis of the Antitumor Monoterpene Indole Alkaloid Camptothecin.

ACS chemical biology·2026
Same journal

Intracellular Delivery of Peptides and Proteins with an Engineered Membrane Translocation Domain.

ACS chemical biology·2026
Same journal

Development of Next-Generation Fluoroacetamidine-Containing Activity-Based Probes for the Selective Labeling of the Protein Arginine Deiminases (PADs).

ACS chemical biology·2026
Same journal

Spectroelectrochemical Insight into Reaction Mechanisms of Cell-Penetrating Peptides on Charged Membrane Surfaces.

ACS chemical biology·2026
See all related articles

Pateamine A, a marine natural product, targets eukaryotic initiation factor 4A (eIF4A). This finding highlights natural products

Area of Science:

  • Marine natural product chemistry
  • Molecular biology
  • Cancer research

Background:

  • Cytotoxic marine natural products offer unique chemical scaffolds.
  • Regulation of eukaryotic translation is crucial for cellular function.
  • Pateamine A is a known cytotoxic marine natural product.

Purpose of the Study:

  • To elucidate the molecular target of pateamine A.
  • To understand the role of pateamine A in regulating translation.
  • To explore pateamine A as a potential cancer therapeutic.

Main Methods:

  • Biochemical assays to identify protein interactions.
  • Cell-based assays to assess translation inhibition.
  • Structural biology to understand binding interactions.

Related Experiment Videos

Main Results:

  • Pateamine A directly binds to and inhibits eukaryotic initiation factor 4A (eIF4A).
  • Inhibition of eIF4A by pateamine A disrupts cap-dependent translation.
  • This mechanism offers a novel approach to cancer chemotherapy.

Conclusions:

  • Pateamine A is a potent inhibitor of eIF4A, a key translation factor.
  • Targeting eIF4A with small molecules like pateamine A represents a promising strategy for cancer treatment.
  • Further research into pateamine A and related compounds could yield new chemotherapeutic agents.